Multiple Sclerosis/ms Clinical Trials
- BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
Multiple Sclerosis
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00001248 - Recruiting
Multiple Sclerosis
- Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
ClinicalTrials.gov Identifier: NCT00289159 - Active, not recruiting
Multiple Sclerosis
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
ClinicalTrials.gov Identifier: NCT00288626 - Recruiting
Multiple Sclerosis
- Stress Management for Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00147446 - Recruiting
Multiple Sclerosis
- Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00559702 - Recruiting
Secondary Progressive Multiple Sclerosis
- Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
ClinicalTrials.gov Identifier: NCT00232193 - Recruiting
Relapsing-Remitting Multiple Sclerosis,; Mono-Symptomatic Multiple Sclerosis
- Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early MS Treatment With Betaseron
ClinicalTrials.gov Identifier: NCT00461396 - Recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00537082 - Recruiting
Multiple Sclerosis
- Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00086671 - Completed
Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
ClinicalTrials.gov Identifier: NCT00337779 - Active, not recruiting
Relapsing Remitting Multiple Sclerosis
- Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00245622 - Active, not recruiting
Clinically Isolated Syndrome (CIS); Relapse-Remitting Multiple Sclerosis (RR-MS)
- Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00001781 - Completed
Multiple Sclerosis
- T-Cell Vaccination in Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00220428 - Recruiting
Multiple Sclerosis
- A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone
ClinicalTrials.gov Identifier: NCT00240006 - Active, not recruiting
Multiple Sclerosis
- A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
Multiple Sclerosis
- Study of SB-683699 Compared to Placebo in Subjects With Relapsing-Remitting Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00395317 - Recruiting
Relapsing Remitting Multiple Sclerosis
- Safety of RG2077 in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Auditory Function in Patients With and Without Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
Multiple Sclerosis
- Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
Multiple Sclerosis
- Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
Multiple Sclerosis
- Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
ClinicalTrials.gov Identifier: NCT00211887 - Recruiting
Relapsing Remitting Multiple Sclerosis
- Cognitive Effects of Immunomodulatory Drugs in MS
ClinicalTrials.gov Identifier: NCT00229502 - Active, not recruiting
Multiple Sclerosis
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
Multiple Sclerosis
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
Multiple Sclerosis
- Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients with Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00079495 - Completed
Multiple Sclerosis
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
Multiple Sclerosis
- Improving Memory in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00062972 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00099307 - Recruiting
Multiple Sclerosis
- Treating New Learning in MS
ClinicalTrials.gov Identifier: NCT00166283 - Recruiting
Multiple Sclerosis
- Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
ClinicalTrials.gov Identifier: NCT00151801 - Recruiting
Multiple Sclerosis
- Observational Study to Determine Impact of Multiple NAb Tests on Treatment Patterns Compared to the Usual Care of MS Patients Receiving High-Dose IFN Therapy.
ClinicalTrials.gov Identifier: NCT00336557 - Recruiting
Multiple Sclerosis
- Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00364936 - Completed
Multiple Sclerosis
- Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
ClinicalTrials.gov Identifier: NCT00391079 - Active, not recruiting
Multiple Sclerosis
- Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
ClinicalTrials.gov Identifier: NCT00492466 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
Multiple Sclerosis
- POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
Multiple Sclerosis
- A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00424788 - Completed
Relapsing Forms of Multiple Sclerosis
- REbif FLEXible Dosing in Early MS
ClinicalTrials.gov Identifier: NCT00404352 - Recruiting
Multiple Sclerosis
- A Study to Test the Use of Duloxetine for Pain in MS
ClinicalTrials.gov Identifier: NCT00457730 - Recruiting
Multiple Sclerosis
- Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
ClinicalTrials.gov Identifier: NCT00464074 - Recruiting
Multiple Sclerosis
- Atorvastatin Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00094172 - Recruiting
Multiple Sclerosis
- A Phase 2 study in Multiple Sclerosis patients to determine the safety of different doses of RO0506997 compared to placebo and their effects on Multiple Sclerosis lesions.
ClinicalTrials.gov Identifier: NCT00104143 - Not yet recruiting
Multiple Sclerosis
- Gene Expression in MS Patients Before and During Treatment With Interferon-Beta
ClinicalTrials.gov Identifier: NCT00202384 - Recruiting
Multiple Sclerosis
- Treadmill Training in Chronic MS: Efficacy and Cost-Effectiveness
ClinicalTrials.gov Identifier: NCT00334100 - Recruiting
Multiple Sclerosis
- Study to Evaluate IV and Oral Steroids for MS Attacks
ClinicalTrials.gov Identifier: NCT00418145 - Recruiting
Multiple Sclerosis
- Assessment of Patients with Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00001156 - Recruiting
Herpesviridae Infection; HTLV-I Infection; Multiple Sclerosis; Tropical Spastic Paraparesis; Vasculitis
- Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
ClinicalTrials.gov Identifier: NCT00510523 - Recruiting
Multiple Sclerosis
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
Multiple Sclerosis
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00001669 - Completed
Multiple Sclerosis
- Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
Multiple Sclerosis
- GER-009-06-AVX Early Therapy in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
ClinicalTrials.gov Identifier: NCT00235430 - Active, not recruiting
Multiple Sclerosis
- Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00262314 - Active, not recruiting
Multiple Sclerosis
- Zenapax to Treat Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00001934 - Active, not recruiting
Multiple Sclerosis
- Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
ClinicalTrials.gov Identifier: NCT00493116 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00289978 - Active, not recruiting
Multiple Sclerosis
- Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00342134 - Active, not recruiting
Multiple Sclerosis
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00381264 - Active, not recruiting
Multiple Sclerosis
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
Multiple Sclerosis
- Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00179478 - Active, not recruiting
Multiple Sclerosis; Optic Neuritis; Transverse Myelitis; Acute Brainstem/Cerebellar Syndrome
- Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS
ClinicalTrials.gov Identifier: NCT00210301 - Recruiting
Relapsing-Remitting Multiple Sclerosis
- Restoration of Walking in Multiple Sclerosis Using Treadmill Training.
ClinicalTrials.gov Identifier: NCT00156676 - Recruiting
Multiple Sclerosis
- Phase II Cladribine Add-on to Rebif New Formulation in MS Subjects With Active Disease (ONWARD)
ClinicalTrials.gov Identifier: NCT00436826 - Recruiting
Multiple Sclerosis
- Treatment of Multiple Sclerosis with Copaxone and Albuterol
ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
Autoimmune Diseases; Multiple Sclerosis
- Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
ClinicalTrials.gov Identifier: NCT00484536 - Recruiting
Multiple Sclerosis
- Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00298662 - Active, not recruiting
Multiple Sclerosis
- Biobank For MS And Other Demyelinating Diseases
ClinicalTrials.gov Identifier: NCT00445367 - Recruiting
Multiple Sclerosis; Transverse Myelitis; Neuromyelitis Optica; Acute Disseminated Encephalomyelitis; Optic Neuritis
- Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment)
ClinicalTrials.gov Identifier: NCT00185211 - Active, not recruiting
Multiple Sclerosis
- Cognitive-Behavior Therapy for MS-Related Chronic Pain
ClinicalTrials.gov Identifier: NCT00323271 - Not yet recruiting
Multiple Sclerosis
- A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis (R-R MS).
ClinicalTrials.gov Identifier: NCT00349193 - Completed
Relapsing Remitting Multiple Sclerosis
- Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
Multiple Sclerosis
- Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
Multiple Sclerosis
- The Effects of TYSABRI Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00536120 - Recruiting
Multiple Sclerosis
- Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study
ClinicalTrials.gov Identifier: NCT00273364 - Recruiting
Multiple Sclerosis
- Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00475865 - Recruiting
Multiple Sclerosis
- A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00217295 - Recruiting
Multiple Sclerosis
- TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00228228 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00321568 - Recruiting
Multiple Sclerosis
- Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00355134 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00393588 - Recruiting
Multiple Sclerosis
- Pilot Study of Teriflunomide as Adjunctive Therapy to Interferon-β in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00489489 - Recruiting
Multiple Sclerosis
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00529581 - Recruiting
Cognition Disorders; Multiple Sclerosis
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study One
ClinicalTrials.gov Identifier: NCT00530348 - Recruiting
Multiple Sclerosis, Relapsing-Remitting
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two
ClinicalTrials.gov Identifier: NCT00548405 - Recruiting
Multiple Sclerosis, Relapsing-Remitting
- Sleep Disorders in Patients with MS
ClinicalTrials.gov Identifier: NCT00137904 - Recruiting
multiple sclerosis, fatigue, sleep disorders
- Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00300716 - Recruiting
Multiple Sclerosis; Cognition Disorders
- Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00324506 - Recruiting
Multiple Sclerosis
- Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
ClinicalTrials.gov Identifier: NCT00331747 - Recruiting
Multiple Sclerosis
- Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00548769 - Recruiting
Multiple Sclerosis
- A Study to Assess the Effects of MK-0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI.
ClinicalTrials.gov Identifier: NCT00239655 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-Remitting Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00292266 - Completed
Multiple Sclerosis, Relapsing-Remitting
- Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
Multiple Sclerosis
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00071838 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00235989 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00296205 - Recruiting
Multiple Sclerosis
- Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00432900 - Recruiting
Multiple Sclerosis
- Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00468182 - Recruiting
Multiple Sclerosis
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
